Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 17137972 | METHOD OF IDENTIFYING SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2) RIBONUCLEIC ACID (RNA) | December 2020 | December 2021 | Allow | 11 | 2 | 1 | Yes | No |
| 17138037 | SYSTEM FOR IDENTIFYING SEVERE ACUTE RESPIRATORY SYNDROME CORONA VIRUS 2 (SARS-COV-2) RIBONUCLEIC ACID (RNA) | December 2020 | November 2021 | Allow | 11 | 2 | 1 | No | No |
| 17247871 | METHOD AND KIT FOR THE DIAGNOSIS OF COLORECTAL CANCER | December 2020 | April 2023 | Abandon | 28 | 2 | 0 | No | No |
| 17129783 | SYSTEM AND SELF-METERING CARTRIDGES FOR POINT OF CARE BIOASSAYS | December 2020 | October 2023 | Allow | 34 | 1 | 1 | No | No |
| 15734760 | USE OF HIGH-TEMPERATURE-RESISTANT CAS PROTEIN, AND METHOD AND REAGENT KIT FOR DETECTING TARGET NUCLEIC ACID MOLECULE | December 2020 | May 2024 | Allow | 42 | 4 | 1 | Yes | No |
| 16951254 | Enzymatic Nucleic Acid Synthesis | November 2020 | April 2023 | Abandon | 28 | 0 | 1 | No | No |
| 16950923 | Method for Accurate Sequencing of DNA | November 2020 | December 2022 | Allow | 25 | 1 | 0 | No | No |
| 17099621 | PENTA E POLYMORPHISMS FOR HUMAN IDENTIFICATION | November 2020 | August 2022 | Allow | 21 | 1 | 1 | No | No |
| 17055514 | A method for controlling timing of events in a microfluidic device and a timer microfluidic device | November 2020 | September 2024 | Abandon | 46 | 1 | 1 | No | No |
| 17080085 | METHODS FOR TEMPERATURE-MEDIATED NESTED POLYMERASE CHAIN REACTION | October 2020 | March 2023 | Allow | 28 | 2 | 0 | Yes | No |
| 17050243 | METHODS | October 2020 | September 2024 | Abandon | 47 | 2 | 0 | No | No |
| 17071988 | METHODS FOR REDUCING BUBBLE FORMATION DURING INCUBATION | October 2020 | August 2022 | Abandon | 22 | 0 | 1 | No | No |
| 17066868 | METHODS FOR GENOME ASSEMBLY AND HAPLOTYPE PHASING | October 2020 | November 2023 | Allow | 37 | 2 | 0 | No | No |
| 17063245 | Nanopore Platform for DNA/RNA Oligo Detection Using an Osmium Tagged Complementary Probe | October 2020 | May 2021 | Allow | 7 | 1 | 1 | No | No |
| 17043539 | NUCLEIC ACID QUANTIFICATION USING CONCENTRATION-SPECIFIC BARCODES | September 2020 | July 2022 | Allow | 22 | 1 | 1 | No | No |
| 17019448 | MICROARRAY SYNTHESIS AND ASSEMBLY OF GENE-LENGTH POLYNUCLEOTIDES | September 2020 | May 2022 | Abandon | 20 | 1 | 0 | No | No |
| 17013810 | NUCLEIC ACID DETECTION METHOD | September 2020 | October 2023 | Abandon | 37 | 2 | 1 | No | No |
| 16977792 | TEMPERATURE CONTROL DEVICE AND GENETIC TESTING DEVICE | September 2020 | April 2023 | Abandon | 31 | 2 | 1 | No | No |
| 17008561 | SYSTEMS, METHODS, AND DEVICES FOR SELF-DIGITIZATION OF SAMPLES | August 2020 | April 2022 | Allow | 19 | 2 | 0 | No | No |
| 16996727 | DETECTION OF WEST NILE VIRUS NUCLEIC ACIDS IN THE VIRAL 3' NON-CODING REGION | August 2020 | February 2024 | Abandon | 42 | 3 | 1 | No | No |
| 16993992 | Methods of Detecting Listeria from an Environmental Sample | August 2020 | September 2021 | Abandon | 13 | 1 | 0 | Yes | No |
| 16993129 | Method For The Determination Of The Fingerprint In Varieties Of Cannabis | August 2020 | November 2023 | Abandon | 39 | 1 | 1 | No | No |
| 16992654 | Methods for Multiplex Imaging Using Labeled Nucleic Acid Imaging Agents | August 2020 | February 2023 | Allow | 30 | 2 | 2 | No | No |
| 16990152 | QUANTITATING HIGH TITER SAMPLES BY DIGITAL PCR | August 2020 | April 2022 | Abandon | 20 | 2 | 0 | No | No |
| 16945553 | COMPOSITIONS AND METHODS FOR DETECTING RARE SEQUENCE VARIANTS | July 2020 | November 2022 | Allow | 28 | 2 | 1 | Yes | No |
| 16966414 | METHODS AND REAGENTS FOR ASSESSING THE PRESENCE OR ABSENCE OF REPLICATION COMPETENT VIRUS | July 2020 | August 2022 | Allow | 25 | 1 | 1 | No | No |
| 16964958 | DETECTION OF NUCLEIC ACID SEQUENCES | July 2020 | June 2024 | Abandon | 46 | 4 | 1 | No | No |
| 16936619 | METHODS FOR NUCLEIC ACID DETECTION | July 2020 | July 2022 | Allow | 24 | 1 | 0 | Yes | No |
| 15733419 | MULTIPLEXED IMMUNOSIGNAL AMPLIFICATION USING HYBRIDIZATION CHAIN REACTION-BASED METHOD | July 2020 | January 2023 | Abandon | 29 | 2 | 1 | No | No |
| 16930882 | MICROFLUIDIC DEVICE FOR PREPARING AND ANALYZING A BIOLOGICAL SAMPLE | July 2020 | July 2023 | Allow | 36 | 1 | 1 | No | No |
| 16930765 | MICROFLUIDIC DEVICE INCLUDING AN AMPLIFICATION REACTION CHAMBER | July 2020 | August 2022 | Allow | 25 | 2 | 1 | No | No |
| 16929032 | METHOD FOR DETECTING NUCLEIC ACID | July 2020 | April 2024 | Abandon | 45 | 3 | 1 | No | No |
| 16926735 | DEVELOPMENT OF SIMPLE SEQUENCE REPEAT (SSR) CORE PRIMER GROUP BASED ON WHOLE GENOME SEQUENCE OF POMEGRANATE AND APPLICATION THEREOF | July 2020 | December 2022 | Abandon | 29 | 1 | 1 | No | No |
| 16644712 | METHOD FOR AMPLIFICATION AND QUANTITATION OF SMALL AMOUNT OF MUTATION USING MOLECULAR BARCODE AND BLOCKING OLIGONUCLEOTIDE | July 2020 | February 2022 | Allow | 23 | 1 | 2 | No | No |
| 16960045 | NUCLEIC ACID TESTS WITH TEMPORAL FLUORESCENT SIGNALS | July 2020 | March 2023 | Abandon | 33 | 2 | 1 | No | No |
| 16958683 | METHOD FOR DETECTING TARGET RNA BY UTILIZING NICKING/EXTENSION CHAIN REACTION SYSTEM- BASED ISOTHERMAL NUCLEIC ACID AMPLIFICATION | June 2020 | June 2022 | Allow | 24 | 0 | 1 | Yes | No |
| 16914109 | MICROFLUIDIC SYSTEM FOR AMPLIFYING AND DETECTING POLYNUCLEOTIDES IN PARALLEL | June 2020 | December 2020 | Allow | 5 | 1 | 1 | Yes | No |
| 16914040 | miRNA Receptivity Analysis of the Endometrium | June 2020 | October 2024 | Abandon | 51 | 5 | 1 | Yes | No |
| 16912132 | COMPOSITIONS AND METHODS FOR IMPROVED DETECTION OF GENOMIC EDITING EVENTS | June 2020 | August 2022 | Abandon | 26 | 0 | 1 | No | No |
| 16912446 | POLYNUCLEOTIDES FOR AMPLIFICATION AND DETECTION OF SARS-COV-2 | June 2020 | March 2021 | Allow | 8 | 0 | 1 | No | No |
| 16912041 | Compositions Containing Identifier Sequences on Solid Supports for Nucleic Acid Sequence Analysis | June 2020 | March 2023 | Allow | 32 | 2 | 1 | No | No |
| 16956609 | LINEAR DOUBLE STRANDED DNA COUPLED TO A SINGLE SUPPORT OR A TAG AND METHODS FOR PRODUCING SAID LINEAR DOUBLE STRANDED DNA | June 2020 | July 2022 | Allow | 25 | 2 | 1 | No | No |
| 16906887 | NUCLEIC ACID AMPLIFICATION | June 2020 | January 2022 | Abandon | 19 | 1 | 0 | No | No |
| 16955702 | DETECTION OF MODIFIED LIVE SWINE INFLUENZA VIRUS VACCINES | June 2020 | January 2023 | Abandon | 31 | 0 | 1 | No | No |
| 16902739 | SELF-CONTAINED BIOLOGICAL ANALYSIS | June 2020 | April 2023 | Allow | 34 | 5 | 0 | Yes | No |
| 16903075 | ENDPOINT DETECTION OF AMPLIFIED NUCLEIC ACIDS | June 2020 | June 2022 | Allow | 24 | 4 | 0 | Yes | No |
| 16902666 | POLYNUCLEOTIDE SEQUENCE DETECTION METHOD | June 2020 | December 2020 | Allow | 6 | 1 | 1 | No | No |
| 16772593 | FLUIDIC CARD ASSEMBLY | June 2020 | January 2023 | Allow | 31 | 1 | 1 | Yes | No |
| 16894481 | Magnetic PCR Assay And Uses Thereof | June 2020 | February 2024 | Abandon | 44 | 3 | 1 | Yes | No |
| 16893356 | METHOD FOR DETECTING MICROORGANISMS | June 2020 | July 2022 | Abandon | 26 | 1 | 1 | No | No |
| 16880754 | Apparatus And Method For Rapid Identification Of Microorganisms | May 2020 | March 2024 | Allow | 46 | 2 | 1 | No | No |
| 16766205 | METHOD FOR DIRECT QUANTIFICATION OF NUCLEIC ACIDS IN REAL TIME qPCR | May 2020 | November 2022 | Allow | 29 | 2 | 1 | Yes | No |
| 16879276 | HIGH-THROUGHPUT GENOTYPING BY SEQUENCING LOW AMOUNTS OF GENETIC MATERIAL | May 2020 | April 2022 | Abandon | 23 | 2 | 1 | No | No |
| 16868403 | RAPID NUCLEIC ACID DETECTION WITHOUT SAMPLE PREPARATION | May 2020 | February 2023 | Allow | 33 | 2 | 0 | No | No |
| 16761235 | DIGITAL NUCLEIC ACID AMPLIFICATION USING ENCODED PARTICLES | May 2020 | July 2023 | Allow | 39 | 4 | 1 | No | No |
| 16850713 | METHODS TO AMPLIFY HIGHLY UNIFORM AND LESS ERROR PRONE NUCLEIC ACID LIBRARIES | April 2020 | July 2023 | Allow | 39 | 6 | 0 | No | No |
| 16846932 | COMPOSITIONS, METHODS, SYSTEMS AND KITS FOR TARGET NUCLEIC ACID ENRICHMENT | April 2020 | July 2021 | Allow | 15 | 1 | 1 | No | No |
| 16840610 | COMPOSITIONS AND METHODS FOR DETECTION OF ZIKA VIRUS | April 2020 | August 2021 | Allow | 17 | 2 | 1 | No | No |
| 16824665 | Method of Removing Nucleic Acids From Human Plasma | March 2020 | March 2022 | Allow | 24 | 1 | 0 | No | No |
| 16817733 | METHODS AND SYSTEMS FOR AUTOMATED SAMPLE PROCESSING | March 2020 | February 2024 | Allow | 47 | 4 | 1 | Yes | No |
| 16815323 | LISTERIA DETECTION | March 2020 | March 2022 | Allow | 25 | 2 | 1 | Yes | No |
| 16809131 | COMPOSITIONS AND METHODS FOR OBTAINING NUCLEIC ACIDS FROM SPUTUM | March 2020 | June 2022 | Abandon | 27 | 0 | 1 | No | No |
| 16641946 | Method for Producing Double-Stranded DNA Fragments | February 2020 | November 2023 | Abandon | 45 | 4 | 0 | Yes | No |
| 16798283 | PCR ASSAYS FOR SPECIFIC DETECTION OF ENTEROCYTOZOON HEPATOPENAEI | February 2020 | April 2022 | Allow | 26 | 2 | 1 | Yes | No |
| 16793732 | PRODUCTS AND PROCESSES FOR MULTIPLEX NUCLEIC ACID IDENTIFICATION | February 2020 | January 2023 | Allow | 35 | 3 | 0 | No | No |
| 16793632 | MICROARRAY SYNTHESIS AND ASSEMBLY OF GENE-LENGTH POLYNUCLEOTIDES | February 2020 | July 2020 | Allow | 5 | 2 | 1 | Yes | No |
| 16790804 | BIOMARKER FOR PROGNOSIS OF COLORECTAL CANCER | February 2020 | May 2022 | Allow | 27 | 2 | 1 | Yes | No |
| 16789279 | MULTIPLEX AMPLIFICATION DETECTION ASSAY II | February 2020 | August 2021 | Allow | 18 | 2 | 0 | No | No |
| 16787977 | MICROFLUIDIC SYSTEM FOR AMPLIFYING AND DETECTING POLYNUCLEOTIDES IN PARALLEL | February 2020 | July 2021 | Allow | 17 | 1 | 0 | Yes | No |
| 16781973 | Serum/plasma LncRNA marker composition associated with auxiliary diagnosis of intrahepatic cholestasis of pregnancy and application thereof | February 2020 | March 2023 | Abandon | 37 | 2 | 1 | No | No |
| 16743377 | AMPLICON GENERATION | January 2020 | June 2022 | Abandon | 29 | 2 | 1 | No | No |
| 16741299 | SYSTEM AND METHOD FOR DETERMINING COPIES-PER-UNIT-VOLUME USING PCR AND FLOW CONTROL OF DROPLETS | January 2020 | March 2023 | Abandon | 38 | 4 | 1 | Yes | No |
| 16629150 | Method for Detecting a Mutation in a Microsatellite Sequence | January 2020 | December 2022 | Abandon | 35 | 2 | 1 | No | No |
| 16627453 | METHOD FOR NUCLEIC ACID DETECTION | December 2019 | April 2022 | Abandon | 28 | 1 | 0 | No | No |
| 16727618 | METHOD FOR SEQUENCING A POLYNUCLEOTIDE TEMPLATE | December 2019 | November 2022 | Allow | 35 | 3 | 1 | No | No |
| 16715270 | Methods and Compositions for the Analysis of Biological Molecules | December 2019 | November 2021 | Abandon | 23 | 1 | 1 | No | No |
| 16714208 | METHODS FOR NUCLEIC ACID ASSEMBLY AND HIGH THROUGHPUT SEQUENCING | December 2019 | June 2021 | Allow | 18 | 1 | 0 | No | No |
| 16713491 | FAST PCR FOR STR GENOTYPING | December 2019 | May 2022 | Allow | 29 | 3 | 1 | No | No |
| 16619944 | THREE MOLECULAR MARKERS, KITS AND APPLICATIONS FOR GLAUCOMA DIAGNOSIS | December 2019 | December 2021 | Abandon | 24 | 0 | 1 | No | No |
| 16619508 | IONIC SPECIES INTERROGATION AND SENSING | December 2019 | October 2022 | Allow | 35 | 2 | 1 | No | No |
| 16693042 | METHOD OF IDENTIFYING SEQUENCE VARIANTS USING CONCATENATION | November 2019 | May 2021 | Allow | 18 | 1 | 1 | No | No |
| 16686663 | SEQUENCING METHODS AND KITS | November 2019 | March 2023 | Abandon | 40 | 3 | 1 | No | No |
| 16686460 | MULTIPLEX DIAGNOSTIC ASSAYS FOR LYME DISEASE AND OTHER TICK-BORNE DISEASES | November 2019 | January 2022 | Allow | 26 | 3 | 0 | No | No |
| 16613593 | SINGLE NUCLEOTIDE DETECTION METHOD AND ASSOCIATED PROBES | November 2019 | October 2023 | Allow | 47 | 4 | 1 | Yes | No |
| 16609073 | MICRO-FLUIDIC DEVICE FOR RAPID PCR | October 2019 | August 2021 | Allow | 21 | 0 | 1 | No | No |
| 16660819 | ASSAY CARTRIDG FOR MOLECULAR DIAGNOSIS | October 2019 | March 2023 | Allow | 40 | 3 | 0 | Yes | No |
| 16606368 | SEQUENTIAL ENCAPSULATION OF REAGENTS | October 2019 | February 2023 | Allow | 39 | 2 | 1 | Yes | No |
| 16655028 | DIAGNOSTIC SYSTEM | October 2019 | January 2021 | Allow | 15 | 2 | 1 | Yes | No |
| 16605728 | NANOPORE/NANOWELL ELECTRODE ENABLED EXONUCLEASE SEQUENCING | October 2019 | April 2023 | Allow | 42 | 2 | 1 | Yes | No |
| 16592992 | DETECTION METHOD AND DEVICE | October 2019 | December 2022 | Allow | 38 | 4 | 1 | No | No |
| 16495614 | System for Rapid, Portable, and Multiplexed Detection and Identification of Pathogen Specific Nucleic Acid Sequences | September 2019 | January 2023 | Allow | 40 | 2 | 1 | No | No |
| 16575205 | Quantification of Mutant Alleles and Copy Number Variation Using Digital PCR with Nonspecific DNA-Binding Dyes | September 2019 | October 2021 | Abandon | 25 | 2 | 0 | No | No |
| 16491141 | METHOD FOR DETECTING A GENOMIC REARRANGEMENT INVOLVING THE ALK GENE IN CELL-FREE DNA | September 2019 | October 2020 | Allow | 13 | 2 | 1 | Yes | No |
| 16556840 | DEVICE AND METHOD FOR DETECTING NUCLEIC ACID | August 2019 | July 2022 | Abandon | 34 | 0 | 1 | No | No |
| 16553592 | GENETIC POLYMORPHISMS ASSOCIATED WITH CORONARY EVENTS AND DRUG RESPONSE, METHODS OF DETECTION AND USES THEREOF | August 2019 | December 2020 | Allow | 16 | 0 | 1 | No | No |
| 16489111 | SYSTEM AND METHOD FOR PURIFYING AND AMPLIFYING NUCLEIC ACIDS | August 2019 | January 2024 | Abandon | 53 | 3 | 1 | No | No |
| 16552737 | Methods for Treating Colorectal Cancer Using Prognostic Genetic Markers | August 2019 | October 2021 | Allow | 25 | 0 | 0 | No | No |
| 16487105 | GENE DETECTION METHOD, GENE DETECTION KIT AND GENE DETECTION DEVICE | August 2019 | November 2022 | Allow | 39 | 1 | 1 | Yes | No |
| 16455470 | METHOD AND KIT FOR DETERMINING THE GENOME INTEGRITY AND/OR THE QUALITY OF A LIBRARY OF DNA SEQUENCES OBTAINED BY DETERMINISTIC RESTRICTION SITE WHOLE GENOME AMPLIFICATION | June 2019 | August 2021 | Abandon | 26 | 2 | 1 | Yes | No |
| 16474496 | FAST PCR WITH MOLECULAR CROWDING | June 2019 | March 2024 | Abandon | 56 | 5 | 1 | Yes | No |
This analysis examines appeal outcomes and the strategic value of filing appeals for examiner KIM, YOUNG J.
With a 0.0% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is in the bottom 25% across the USPTO, indicating that appeals face significant challenges here.
Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.
In this dataset, 15.0% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.
⚠ Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.
⚠ Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.
Examiner KIM, YOUNG J works in Art Unit 1637 and has examined 1,005 patent applications in our dataset. With an allowance rate of 48.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 35 months.
Examiner KIM, YOUNG J's allowance rate of 48.0% places them in the 12% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by KIM, YOUNG J receive 2.31 office actions before reaching final disposition. This places the examiner in the 61% percentile for office actions issued. This examiner issues a slightly above-average number of office actions.
The median time to disposition (half-life) for applications examined by KIM, YOUNG J is 35 months. This places the examiner in the 38% percentile for prosecution speed. Prosecution timelines are slightly slower than average with this examiner.
Conducting an examiner interview provides a +30.4% benefit to allowance rate for applications examined by KIM, YOUNG J. This interview benefit is in the 77% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 17.6% of applications are subsequently allowed. This success rate is in the 18% percentile among all examiners. Strategic Insight: RCEs show lower effectiveness with this examiner compared to others. Consider whether a continuation application might be more strategic, especially if you need to add new matter or significantly broaden claims.
This examiner enters after-final amendments leading to allowance in 37.7% of cases where such amendments are filed. This entry rate is in the 58% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.
When applicants request a pre-appeal conference (PAC) with this examiner, 57.1% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 49% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.
This examiner withdraws rejections or reopens prosecution in 79.5% of appeals filed. This is in the 71% percentile among all examiners. Of these withdrawals, 80.6% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.
When applicants file petitions regarding this examiner's actions, 60.7% are granted (fully or in part). This grant rate is in the 63% percentile among all examiners. Strategic Note: Petitions show above-average success regarding this examiner's actions. Petitionable matters include restriction requirements (MPEP § 1002.02(c)(2)) and various procedural issues.
Examiner's Amendments: This examiner makes examiner's amendments in 4.4% of allowed cases (in the 85% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.1% of allowed cases (in the 80% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.